Down-regulation of Lsm1 is involved in human prostate cancer progression

Elucidation of genetic alterations is an approach to understanding the underlying molecular mechanisms of progression of human prostate cancers. We have searched for genes differentially expressed in advanced prostate cancers using cDNA-representational difference analysis, and thereby isolated the Lsm1 as one of down-regulated gene. An Lsm1 expression vector was transfected into PC3 cells, normally featuring down-regulated Lsm1, and four transfectants were established. No differences in morphology or cell proliferation were evident in comparison with parent PC3 or PC3/mock-transfectants. In contrast, significant suppression of invasive potential or metastatic ability of Lsm1 transfectants was observed in the Matrigel chemoinvasion assay and in nude mice, respectively. With human prostate cancers, almost all of informative prostatectomised cases without neoadjuvant therapy showed allelic retention in the Lsm1 region, whereas refractory cancers frequently showed allelic loss in this region. No critical gene mutations were found in open reading frame of Lsm1 in prostate cancers examined by PCR–SSCP analysis, including localised and refractory cancers. These results suggest that Lsm1 is deeply involved in prostate cancer progression through its down-regulation, independent of any gene mutation.

[1]  Y. Iida.  Quantification analysis of 5'-splice signal sequences in mRNA precursors. Mutations in 5'-splice signal sequence of human beta-globin gene and beta-thalassemia. , 1990, Journal of theoretical biology.

[2]  M. Wilm,et al.  A doughnut‐shaped heteromer of human Sm‐like proteins binds to the 3′‐end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro , 1999, The EMBO journal.

[3]  J. Macoska,et al.  Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: Identification of a potential tumor suppressor gene site , 1998, Genes, chromosomes & cancer.

[4]  A. Brothman,et al.  Chromosomal clues to the development of prostate tumors , 1999, The Prostate.

[5]  J. Neoptolemos,et al.  Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer , 1996, International journal of cancer.

[6]  M. Hendrix,et al.  A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. , 1987, Cancer letters.

[7]  K. Nakashiro,et al.  Androgen receptor expression in androgen‐independent prostate cancer cell lines , 2001, The Prostate.

[8]  D. Watson,et al.  CaSm: an Sm-like protein that contributes to the transformed state in cancer cells. , 1997, Cancer research.

[9]  J. Neoptolemos,et al.  Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer , 1999, Oncogene.

[10]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[11]  Yôichi Iida,et al.  Quantification analysis of 5'-splice signal sequences in mRNA precursors. Mutations in 5'-splice signal sequence of human β-globin gene and β-thalassemia , 1990 .

[12]  Bertrand Séraphin,et al.  Sm and Sm‐like proteins assemble in two related complexes of deep evolutionary origin , 1999, The EMBO journal.

[13]  J. Barrett,et al.  Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer , 1997, The Prostate.

[14]  J. Ferlay,et al.  Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden , 1993, International journal of cancer.

[15]  C. Osborne,et al.  Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. , 1985, Cancer research.

[16]  C. Croce,et al.  Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Y. Hosoya,et al.  Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Sachs,et al.  Capped mRNA Degradation Intermediates Accumulate in the Yeast spb8-2 Mutant , 1998, Molecular and Cellular Biology.

[19]  S. Pathak,et al.  Genetic alterations in human prostate cancer: a review of current literature. , 2000, Anticancer Research.

[20]  J. Isaacs,et al.  CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. , 1997, Cancer research.

[21]  D. Grignon,et al.  Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. , 1995, Cancer research.

[22]  R. Lidereau,et al.  Genetic aspects of prostate cancer , 1998, Virchows Archiv.

[23]  W. Isaacs,et al.  Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. , 1996, Cancer research.

[24]  S. Devesa,et al.  International trends and patterns of prostate cancer incidence and mortality , 2000, International journal of cancer.

[25]  J. Chudek,et al.  Microsatellite analysis reveals deletion of a large region at chromosome 8p in conventional renal cell carcinoma , 1999, International journal of cancer.

[26]  J. Barrett,et al.  KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.

[27]  Jean D. Beggs,et al.  Yeast Sm-like proteins function in mRNA decapping and decay , 2000, Nature.

[28]  M Hubank,et al.  Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.

[29]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[30]  R. Verma,et al.  Chromosomal basis of adenocarcinoma of the prostate. , 1999, Cancer investigation.